As both S100A8/A9 are prognostic markers for patients with pancreatic cancer [20,42], with those with a higher expression having a poorer OS, we believe that the expression levels of both CD74 and S100A8/A9 can also be crucial prognostic markers in PDAC. This evidence concerns the gene CD74 and familial pancreatic carcinoma.